Simcere Pharmaceutical Co., Ltd

This study tests an experimental drug called SIM0718 for people with eosinophilic asthma, a type often triggered by allergies. About 418 adults and teens aged 12–75 who still have symptoms despite standard inhalers will receive either SIM0718 or a placebo for one year. The main g…

This study tests a new tablet (edaravone dexborneol) to see if it can improve thinking and memory problems that happen after a stroke. About 226 adults who recently had a stroke and have some cognitive issues will take the tablet or a placebo for 24 weeks. The goal is to find out…

This study tests an oral medicine called deurremidevir in infants and young children (1 month to 3 years old) with RSV infection. About 498 children will receive either the drug or a placebo for 5 days. The goal is to see if the drug helps relieve symptoms like wheezing and rapid…